🟢 Novavax is trading 5% up as vaccine stocks rallied on Russian plague concerns

Novavax is trading at $13.22, up 5.29%, amid a vaccine-sector rally linked to reports of an unexplained death at a Russian plague research institute.

• Traders speculated that heightened infectious-disease concerns could bring government preparedness spending, though Novavax does not make a plague vaccine.
• The prior session’s 20.08% rise was also reported amid the Russian plague scare and broader vaccine-stock buying. No new Novavax-specific announcement explaining the October 6 move was identified.